Press Releases Keyword Search Year None202120202019201820172016201520142013 February 25, 2021 Editas Medicine Announces Fourth Quarter and Full Year 2020 Results and Update February 18, 2021 Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update February 8, 2021 Editas Medicine Announces Appointment of James C. Mullen as Chief Executive Officer January 20, 2021 Editas Medicine Announces Pricing of Offering of Common Stock January 19, 2021 Editas Medicine Announces Offering of Common Stock January 11, 2021 Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference January 11, 2021 Editas Medicine Announces the FDA has Cleared Initiation of the EDIT-301 Clinical Trial January 11, 2021 Editas Medicine Announces Transition of Chief Scientific Officer January 4, 2021 Editas Medicine to Present at the 39th Annual J.P. Morgan Healthcare Conference
February 18, 2021 Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results and Corporate Update
January 11, 2021 Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference
January 11, 2021 Editas Medicine Announces the FDA has Cleared Initiation of the EDIT-301 Clinical Trial
